PanGen Biotech Inc. (KOSDAQ:222110)
South Korea
· Delayed Price · Currency is KRW 4,680.00
-100.00 (-2.09%)
Last updated: Mar 31, 2025
PanGen Biotech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 943.69 | -4,489 | -4,494 | -3,310 | -4,356 | Upgrade
|
| Depreciation & Amortization | 1,468 | 1,597 | 1,603 | 1,532 | 1,568 | Upgrade
|
| Loss (Gain) From Sale of Assets | -13.77 | -15.15 | 0.24 | 0.67 | 0.03 | Upgrade
|
| Stock-Based Compensation | - | 12.18 | 236.78 | 224.6 | 27.99 | Upgrade
|
| Provision & Write-off of Bad Debts | 148.57 | 148.57 | - | - | - | Upgrade
|
| Other Operating Activities | 658.54 | 1,052 | 642.78 | 693.36 | 1,546 | Upgrade
|
| Change in Accounts Receivable | -746.76 | -1,659 | 386.46 | -552.25 | -482.92 | Upgrade
|
| Change in Inventory | 930.24 | -752.12 | -2,257 | -608.69 | -2,964 | Upgrade
|
| Change in Accounts Payable | 124.51 | 43.34 | -126.43 | 85.41 | -305.19 | Upgrade
|
| Change in Other Net Operating Assets | -526.46 | 612.11 | 505.41 | -1,389 | 285.19 | Upgrade
|
| Operating Cash Flow | 2,987 | -3,451 | -3,503 | -3,324 | -4,681 | Upgrade
|
| Capital Expenditures | -360.06 | -422.13 | -728.05 | -1,425 | -755.64 | Upgrade
|
| Sale of Property, Plant & Equipment | 150 | 15.2 | 34.62 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -14.07 | -62.86 | -5.8 | -49.29 | -16.73 | Upgrade
|
| Investment in Securities | -10,077 | -50 | 15,048 | -4,451 | 9,542 | Upgrade
|
| Other Investing Activities | -35.8 | -51.34 | -119.4 | -100.22 | -352.79 | Upgrade
|
| Investing Cash Flow | -10,337 | -571.13 | 14,229 | -6,026 | 8,417 | Upgrade
|
| Short-Term Debt Issued | 980 | 986 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 3,204 | 60.19 | 68.91 | 77.31 | Upgrade
|
| Total Debt Issued | 980 | 4,190 | 60.19 | 68.91 | 77.31 | Upgrade
|
| Short-Term Debt Repaid | -980 | -986 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -516.88 | -1.56 | -18,829 | -1.04 | - | Upgrade
|
| Total Debt Repaid | -1,497 | -987.56 | -18,829 | -1.04 | - | Upgrade
|
| Net Debt Issued (Repaid) | -516.88 | 3,202 | -18,769 | 67.88 | 77.31 | Upgrade
|
| Issuance of Common Stock | 9,261 | - | 33.68 | 10,051 | - | Upgrade
|
| Other Financing Activities | -9.43 | -27.34 | -0.51 | -6.16 | - | Upgrade
|
| Financing Cash Flow | 8,735 | 3,175 | -18,736 | 10,112 | 77.31 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | -37.7 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0 | -0 | - | Upgrade
|
| Net Cash Flow | 1,385 | -847.06 | -8,009 | 762.18 | 3,776 | Upgrade
|
| Free Cash Flow | 2,627 | -3,873 | -4,231 | -4,749 | -5,437 | Upgrade
|
| Free Cash Flow Margin | 17.90% | -52.94% | -65.08% | -59.85% | -87.81% | Upgrade
|
| Free Cash Flow Per Share | 228.26 | -362.36 | -396.34 | -464.83 | -564.12 | Upgrade
|
| Cash Interest Paid | 1.15 | 2.29 | 0.53 | 0.53 | - | Upgrade
|
| Cash Income Tax Paid | 69.84 | -39.51 | 79.39 | 34.79 | -45.94 | Upgrade
|
| Levered Free Cash Flow | 228.45 | -1,012 | -2,828 | -4,331 | -6,138 | Upgrade
|
| Unlevered Free Cash Flow | 429.76 | -874.1 | -2,748 | -4,148 | -5,505 | Upgrade
|
| Change in Net Working Capital | 1,302 | -655.07 | 747.77 | 2,150 | 3,988 | Upgrade
|
Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.